Immune effector cell mediated neurotoxicity syndrome
Showing 1 - 25 of >10,000
Immune Effector Cell-Associated Neurotoxicity Syndrome
Not yet recruiting
- Immune Effector Cell Associated Neurotoxicity Syndrome
- (no location specified)
Dec 1, 2022
Lymphoma, B-Cell, Neurotoxicity Trial in Montpellier (Magnetic Resonance Imaging with contrast injection, Blood withdrawal,
Not yet recruiting
- Lymphoma, B-Cell
- Neurotoxicity
- Magnetic Resonance Imaging with contrast injection
- +2 more
-
Montpellier, Occitanie, FranceNeurology department, Montpellier University Hospital
Aug 19, 2022
EEG Encephalopathy Patterns in Immune Effectors Cells-associated
Completed
- Immune Effector Cell Encephalopathy
- Neurotoxicity
-
Montpellier, FranceUhmontpellier
Apr 11, 2022
Cytokine Release Syndrome, ICANS, Lymphoma, Non-Hodgkin Trial in Birmingham (Siltuximab)
Recruiting
- Cytokine Release Syndrome
- +4 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Nov 17, 2021
Non Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma Trial in Boston (Anakinra, Axicabtagene
Recruiting
- Non Hodgkin Lymphoma
- +5 more
- Anakinra
- Axicabtagene Ciloleucel
-
Boston, Massachusetts
- +1 more
Oct 28, 2021
Lymphoma, Lymphoma, B-Cell, Immune System Diseases Trial in Chapel Hill (iC9-CAR19 T cells, Bendamustine, Fludarabine)
Recruiting
- Lymphoma
- +4 more
- iC9-CAR19 T cells
- +4 more
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
Dec 2, 2022
Using IMC to Analyze the Impact of ICANS on Microglia
Recruiting
- ICANS, Grade Unspecified
- CAR T-Cell-Related Encephalopathy Syndrome
- There will be no intervention as we will study patients that undergo autopsy after CAR T cell infusion.
-
Freiburg, Baden Württemberg, GermanyFreiburg University Medical Center
Apr 12, 2023
Acute Lymphoblastic Leukemia, Immune System Diseases, Immunoproliferative Disorders Trial in Chapel Hill (iC9-CAR19 cells,
Recruiting
- Acute Lymphoblastic Leukemia
- +2 more
- iC9-CAR19 cells
- +3 more
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
Dec 21, 2022
Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Non-Hodgkin Lymphoma, Refractory B Acute Lymphoblastic Leukemia Trial
Not yet recruiting
- Recurrent B Acute Lymphoblastic Leukemia
- +5 more
- Interferon Beta-1A
- +10 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 6, 2023
B-Cell Non-Hodgkin Lymphoma Trial in Seattle (Anakinra)
Recruiting
- B-Cell Non-Hodgkin Lymphoma
- Anakinra
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 11, 2023
Non-Hodgkin Lymphoma Trial in Columbus (Biospecimen Collection, Computed Tomography, Positron Emission Tomography)
Recruiting
- Non-Hodgkin Lymphoma
- Biospecimen Collection
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Jan 13, 2023
Hematologic Malignancy, Large B-cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Los Angeles (autologous hematopoietic stem
Not yet recruiting
- Hematologic Malignancy
- +5 more
- autologous hematopoietic stem cells added to planned CAR T
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
May 31, 2023
Peripheral T Cell Lymphoma Trial in Chapel Hill, Winston-Salem (ATLCAR.CD30 T cells, Bendamustine, Fludarabine)
Recruiting
- Peripheral T Cell Lymphoma
- ATLCAR.CD30 T cells
- +3 more
-
Chapel Hill, North Carolina
- +1 more
Mar 4, 2022
Serum Neurofilament Light asMarker for Brain Injury in
Recruiting
- Neurotoxicity
-
Saint Louis, MissouriWashington University School of Medicine
Oct 10, 2022
Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell Trial in United Kingdom (ALETA-001)
Not yet recruiting
- Lymphoma, Non-Hodgkin
- +4 more
-
Birmingham, United Kingdom
- +5 more
Sep 18, 2023
Parvovirus B19 Infection in Hereditary Hemolytic Anemias
Active, not recruiting
- Parvovirus B19 Infection
- Supportive treatment with or without red cell transfusion/intravenous immune globulin (IVIG)
-
Sohag, Egypt, Faculty of Medicine, Sohag University
Mar 25, 2021
AML/MDS Trial in Copenhagen (iDLI)
Recruiting
- AML/MDS
- iDLI
-
Copenhagen, DenmarkCopenhagen University Hospital, Rigshospitalet
Jan 13, 2023
Pupillary Assessment to Predict CAR-T Related Neurotoxicity
Not yet recruiting
- Neurotoxicity
- NeurOptics® NPi®-300 Pupillometer
-
Houston, TexasMD Anderson Cancer Center
Nov 16, 2023
Precision Diagnostics in Inflammatory Bowel Disease, Cellular
Enrolling by invitation
- Graft Vs Host Disease
- +2 more
-
Boston, Massachusetts
- +1 more
Dec 7, 2022
AIDS-Related Diffuse Large B-cell Lymphoma, AIDS-Related Non-Hodgkin Lymphoma, HIV Infection Trial (Axicabtagene Ciloleucel,
Not yet recruiting
- AIDS-Related Diffuse Large B-cell Lymphoma
- +14 more
- Axicabtagene Ciloleucel
- +2 more
- (no location specified)
Feb 15, 2022
Relapsed Acute Myeloid Leukemia Trial in Saint Louis (Flotetuzumab, Donor lymphocyte infusion)
Recruiting
- Relapsed Acute Myeloid Leukemia
- Flotetuzumab
- Donor lymphocyte infusion
-
Saint Louis, MissouriWashington University School of Medicine
Sep 7, 2022
Dd-cfDNA and Treg in Prediction of Kidney Transplant Acute
Recruiting
- Acute Rejection of Renal Transplant
- Graft Failure
- Donor-derived cell-free DNA
-
Loma Linda, CaliforniaLoma Linda University Health
Jul 19, 2022
And Immuno-meDIated Adverse Events in Anti-cancer
Not yet recruiting
- Cancer
- (no location specified)
Jun 26, 2023
Metastatic Melanoma, Metastatic Breast Cancer, Advanced Renal Cell Carcinoma Trial in Worldwide (single arm)
Withdrawn
- Metastatic Melanoma
- +5 more
- single arm
- (no location specified)
Dec 20, 2022